Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs JPMorgan Ultra Short Income ETF (JPST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs JPMorgan Ultra Short Income ETF — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while JPMorgan Ultra Short Income ETF trades at $50.3 (market cap $42.37B). The key difference: JPMorgan Ultra Short Income ETF is far larger — about 3.4× Halozyme Therapeutics Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and JPMorgan Ultra Short Income ETF for 47 Days on average.
| HALO | JPST | |
|---|---|---|
Market Cap | $12.58B | $42.37B |
Volume | 2,179,278 | 7,889,185 |
Sector | Health | Fixed Income |
52-Week High | $115.22 | $50.78 |
52-Week Low | $61.63 | $50.22 |
Typical Hold Time | 1 Days | 47 Days |
Enterprise Value | $14.49B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JPST trades at $50.27 with no recent price movement, showing stability amid bearish technical signals from moving averages. The ETF maintains consistent dividend distributions of $0.17 monthly, positioning as a cash-equivalent alternative. Recent news highlights institutional position adjustments and growing investor interest in ultra-short income strategies as rates rise.
The outlook remains stable for income-focused investors seeking minimal volatility. Key risks include interest rate sensitivity and active management performance versus peers. Recent institutional selling activity suggests some profit-taking despite the fund's role in portfolio cash management strategies.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About JPMorgan Ultra Short Income ETF
JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →
